VRTX
Vertex Pharmaceuticals Incorporated
NMS
$423.00
-2.09
(-0.49%)
Pullback · -1.18σ
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$107.4B
P/E ttm
25.1
Fwd P/E
19.7
Beta
0.30
Day range
$423.00
52w range
$412.27 – $507.92
Avg vol
1.3M
RSI(2)
6.4
ROE
24.2%
Net mgn
35.5%
FCF mgn
22.8%
Debt/Eq
0.10
Div yld
—
Sector
Healthcare
Industry
Biotechnology
Next earn
2026-08-03
Matrix setup grades
Long
—
score 17 · tech 17 / 80 · support 0 / 20
KC1 lower, -1.16 ATR from EMA21 · no notable pattern
- · KC1 lower stretch — light dip
Short
—
score 12 · tech 12 / 80 · support 0 / 20
below KC1 upper, -1.16 ATR from EMA21 · no notable pattern
- · Aligned with weak downtrend
Options · swing
See more →
CALL
$440
2026-07-17
$12.05
PUT
$430
2026-07-17
$19.55
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-05-04
- EPS (act / est)
- 4.47 / 4.31
- Surprise
- +3.8%
- Next report
- 2026-08-03
About
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRI…